1
|
Floege J and Amann K: Primary
glomerulonephritides. Lancet. 387:2036–2048. 2016.PubMed/NCBI View Article : Google Scholar
|
2
|
Caliskan Y and Kiryluk K: Novel biomarkers
in glomerular disease. Adv Chronic Kidney Dis. 21:205–216.
2014.PubMed/NCBI View Article : Google Scholar
|
3
|
Matovinović MS: Podocyte injury in
glomerular diseases. EJIFCC. 20:21–27. 2009.PubMed/NCBI
|
4
|
Mallipattu SK and He JC: The podocyte as a
direct target for treatment of glomerular disease? Am J Physiol
Renal Physiol. 311:F46–F51. 2016.PubMed/NCBI View Article : Google Scholar
|
5
|
Bagavant H and Fu SM: Pathogenesis of
kidney disease in systemic lupus erythematosus. Curr Opin
Rheumatol. 21:489–494. 2009.PubMed/NCBI View Article : Google Scholar
|
6
|
Hogan J, Mohan P and Appel GB: Diagnostic
tests and treatment options in glomerular disease: 2014 update. Am
J Kidney Dis. 63:656–666. 2014.PubMed/NCBI View Article : Google Scholar
|
7
|
Parikh SV, Ayoub I and Rovin BH: The
kidney biopsy in lupus nephritis: Time to move beyond histology.
Nephrol Dial Transplant. 30:3–6. 2015.PubMed/NCBI View Article : Google Scholar
|
8
|
Rovin BH, Almaani S and Malvar A:
Reimagining the kidney biopsy in the era of diagnostic biomarkers
of glomerular disease. Kidney Int. 95:265–267. 2019.PubMed/NCBI View Article : Google Scholar
|
9
|
Kopp F and Mendell JT: Functional
classification and experimental dissection of long noncoding RNAs.
Cell. 172:393–407. 2018.PubMed/NCBI View Article : Google Scholar
|
10
|
Mongelli A, Martelli F, Farsetti A and
Gaetano C: The dark that matters: Long Non-coding RNAs as master
regulators of cellular metabolism in Non-communicable diseases.
Front Physiol. 10(369)2019.PubMed/NCBI View Article : Google Scholar
|
11
|
Lorenzen JM and Thum T: Long noncoding
RNAs in kidney and cardiovascular diseases. Nat Rev Nephrol.
12:360–373. 2016.PubMed/NCBI View Article : Google Scholar
|
12
|
Ignarski M, Islam R and Müller RU: Long
Non-coding RNAs in kidney disease. Int J Mol Sci.
20(3276)2019.PubMed/NCBI View Article : Google Scholar
|
13
|
Tian H, Wu M, Zhou P, Huang C, Ye C and
Wang L: The long non-coding RNA MALAT1 is increased in renal
ischemia-reperfusion injury and inhibits hypoxia-induced
inflammation. Ren Fail. 40:527–533. 2018.PubMed/NCBI View Article : Google Scholar
|
14
|
Hu S, Han R, Shi J, Zhu X, Qin W, Zeng C,
Bao H and Liu Z: The long noncoding RNA LOC105374325 causes
podocyte injury in individuals with focal segmental
glomerulosclerosis. J Biol Chem. 293:20227–20239. 2018.PubMed/NCBI View Article : Google Scholar
|
15
|
Han R, Hu S, Qin W, Shi J, Zeng C, Bao H
and Liu Z: Upregulated long noncoding RNA LOC105375913 induces
tubulointerstitial fibrosis in focal segmental glomerulosclerosis.
Sci Rep. 9(716)2019.PubMed/NCBI View Article : Google Scholar
|
16
|
Jin LW, Pan M, Ye HY, Zheng Y, Chen Y,
Huang WW, Xu XY and Zheng SB: Down-regulation of the long
non-coding RNA XIST ameliorates podocyte apoptosis in membranous
nephropathy via the miR-217-TLR4 pathway. Exp Physiol. 104:220–230.
2019.PubMed/NCBI View
Article : Google Scholar
|
17
|
Liao Z, Ye Z, Xue Z, Wu L, Ouyang Y, Yao
C, Cui C, Xu N, Ma J, Hou G, et al: Identification of renal long
Non-coding RNA RP11-2B6.2 as a positive regulator of type I
interferon signaling pathway in lupus nephritis. Front Immunol.
10(975)2019.PubMed/NCBI View Article : Google Scholar
|
18
|
Santer L, López B, Ravassa S, Baer C,
Riedel I, Chatterjee S, Moreno MU, González A, Querejeta R, Pinet
F, et al: Circulating long noncoding RNA LIPCAR predicts heart
failure outcomes in patients without chronic kidney disease.
Hypertension. 73:820–828. 2019.PubMed/NCBI View Article : Google Scholar
|
19
|
Huang YS, Hsieh HY, Shih HM, Sytwu HK and
Wu CC: Urinary Xist is a potential biomarker for membranous
nephropathy. Biochem Biophys Res Commun. 452:415–421.
2014.PubMed/NCBI View Article : Google Scholar
|
20
|
Forbes JM and Thorburn DR: Mitochondrial
dysfunction in diabetic kidney disease. Nat Rev Nephrol.
14:291–312. 2018.PubMed/NCBI View Article : Google Scholar
|
21
|
Young TL, Matsuda T and Cepko CL: The
noncoding RNA taurine upregulated gene 1 is required for
differentiation of the murine retina. Curr Biol. 15:501–512.
2005.PubMed/NCBI View Article : Google Scholar
|
22
|
Li SY, Park J, Qiu C, Han SH, Palmer MB,
Arany Z and Susztak K: Increasing the level of peroxisome
proliferator-activated receptor γ coactivator-1α in podocytes
results in collapsing glomerulopathy. JCI Insight.
2(e92930)2017.PubMed/NCBI View Article : Google Scholar
|
23
|
Li SY and Susztak K: The long noncoding
RNA Tug1 connects metabolic changes with kidney disease in
podocytes. J Clin Invest. 126:4072–4075. 2016.PubMed/NCBI View
Article : Google Scholar
|
24
|
LeBleu VS, O'Connell JT, Gonzalez Herrera
KN, Wikman H, Pantel K, Haigis MC, de Carvalho FM, Damascena A,
Domingos Chinen LT, Rocha RM, et al: PGC-1α mediates mitochondrial
biogenesis and oxidative phosphorylation in cancer cells to promote
metastasis. Nat Cell Biol. 16:992–1003, 1-15. 2014.PubMed/NCBI View
Article : Google Scholar
|
25
|
Uldry M, Yang W, St-Pierre J, Lin J, Seale
P and Spiegelman BM: Complementary action of the PGC-1 coactivators
in mitochondrial biogenesis and brown fat differentiation. Cell
Metab. 3:333–341. 2006.PubMed/NCBI View Article : Google Scholar
|
26
|
Finck BN and Kelly DP: PGC-1 coactivators:
Inducible regulators of energy metabolism in health and disease. J
Clin Invest. 116:615–622. 2006.PubMed/NCBI View
Article : Google Scholar
|
27
|
Kang HM, Ahn SH, Choi P, Ko YA, Han SH,
Chinga F, Park AS, Tao J, Sharma K, Pullman J, et al: Defective
fatty acid oxidation in renal tubular epithelial cells has a key
role in kidney fibrosis development. Nat Med. 21:37–46.
2015.PubMed/NCBI View
Article : Google Scholar
|
28
|
Long J, Badal SS, Ye Z, Wang Y, Ayanga BA,
Galvan DL, Green NH, Chang BH, Overbeek PA and Danesh FR: Long
noncoding RNA Tug1 regulates mitochondrial bioenergetics in
diabetic nephropathy. J Clin Invest. 126:4205–4218. 2016.PubMed/NCBI View
Article : Google Scholar
|
29
|
Association WM: World medical association
declaration of Helsinki: Ethical principles for medical research
involving human subjects. JAMA. 310:2191–2194. 2013.PubMed/NCBI View Article : Google Scholar
|
30
|
Yu C, Li L, Xie F, Guo S, Liu F, Dong N
and Wang Y: LncRNA TUG1 sponges miR-204-5p to promote osteoblast
differentiation through upregulating Runx2 in aortic valve
calcification. Cardiovasc Res. 114:168–179. 2018.PubMed/NCBI View Article : Google Scholar
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
32
|
Ben-Ari Fuchs S, Lieder I, Stelzer G,
Mazor Y, Buzhor E, Kaplan S, Bogoch Y, Plaschkes I, Shitrit A,
Rappaport N, et al: GeneAnalytics: An integrative gene set analysis
tool for next generation sequencing, RNAseq and microarray data.
OMICS. 20:139–151. 2016.PubMed/NCBI View Article : Google Scholar
|
33
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4(e05005)2015.PubMed/NCBI View Article : Google Scholar
|
34
|
Levey AS, Eckardt KU, Tsukamoto Y, Levin
A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N and
Eknoyan G: Definition and classification of chronic kidney disease:
A position statement from Kidney Disease: Improving Global Outcomes
(KDIGO). Kidney Int. 67:2089–2100. 2005.PubMed/NCBI View Article : Google Scholar
|
35
|
Fukuda A, Wickman LT, Venkatareddy MP,
Wang SQ, Chowdhury MA, Wiggins JE, Shedden KA and Wiggins RC: Urine
podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker.
Nephrol Dial Transplant. 27:4079–4087. 2012.PubMed/NCBI View Article : Google Scholar
|
36
|
Civelek M, Hagopian R, Pan C, Che N, Yang
WP, Kayne PS, Saleem NK, Cederberg H, Kuusisto J, Gargalovic PS, et
al: Genetic regulation of human adipose microRNA expression and its
consequences for metabolic traits. Hum Mol Genet. 22:3023–3037.
2013.PubMed/NCBI View Article : Google Scholar
|
37
|
Saez-Rodriguez J, Rinschen MM, Floege J
and Kramann R: Big science and big data in nephrology. Kidney Int.
95:1326–1337. 2019.PubMed/NCBI View Article : Google Scholar
|
38
|
Kretzler M, Cohen CD, Doran P, Henger A,
Madden S, Gröne EF, Nelson PJ, Schlöndorff D and Gröne HJ:
Repuncturing the renal biopsy: Strategies for molecular diagnosis
in nephrology. J Am Soc Nephrol. 13:1961–1972. 2002.PubMed/NCBI View Article : Google Scholar
|
39
|
Sun IO and Lerman LO: Urinary microRNA in
kidney disease: Utility and roles. Am J Physiol Renal Physiol.
316:F785–F793. 2019.PubMed/NCBI View Article : Google Scholar
|
40
|
Brandenburger T, Salgado Somoza A, Devaux
Y and Lorenzen JM: Noncoding RNAs in acute kidney injury. Kidney
Int. 94:870–881. 2018.PubMed/NCBI View Article : Google Scholar
|
41
|
Patrakka J, Kestilä M, Wartiovaara J,
Ruotsalainen V, Tissari P, Lenkkeri U, Männikkö M, Visapää I,
Holmberg C, Rapola J, et al: Congenital nephrotic syndrome (NPHS1):
Features resulting from different mutations in Finnish patients.
Kidney Int. 58:972–980. 2000.PubMed/NCBI View Article : Google Scholar
|
42
|
Boute N, Gribouval O, Roselli S, Benessy
F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P and Antignac
C: NPHS2, encoding the glomerular protein podocin, is mutated in
autosomal recessive steroid-resistant nephrotic syndrome. Nat
Genet. 24:349–354. 2000.PubMed/NCBI View
Article : Google Scholar
|
43
|
Sekulic M and Pichler Sekulic S: A
compendium of urinary biomarkers indicative of glomerular
podocytopathy. Patholog Res Int. 2013(782395)2013.PubMed/NCBI View Article : Google Scholar
|
44
|
Hara M, Yanagihara T and Kihara I: Urinary
podocytes in primary focal segmental glomerulosclerosis. Nephron.
89:342–347. 2001.PubMed/NCBI View Article : Google Scholar
|
45
|
Szeto CC, Wang G, Chow KM, Lai FM, Ma TK,
Kwan BC, Luk CC and Li PK: Podocyte mRNA in the urinary sediment of
minimal change nephropathy and focal segmental glomerulosclerosis.
Clin Nephrol. 84:198–205. 2015.PubMed/NCBI View Article : Google Scholar
|
46
|
Pätäri A, Forsblom C, Havana M, Taipale H,
Groop PH and Holthöfer H: Nephrinuria in diabetic nephropathy of
type 1 diabetes. Diabetes. 52:2969–2974. 2003.PubMed/NCBI View Article : Google Scholar
|
47
|
Ng DP, Tai BC, Tan E, Leong H, Nurbaya S,
Lim XL, Chia KS, Wong CS, Lim WY and Holthöfer H: Nephrinuria
associates with multiple renal traits in type 2 diabetes. Nephrol
Dial Transplant. 26:2508–2514. 2011.PubMed/NCBI View Article : Google Scholar
|
48
|
Chang JH, Paik SY, Mao L, Eisner W,
Flannery PJ, Wang L, Tang Y, Mattocks N, Hadjadj S, Goujon JM, et
al: Diabetic kidney disease in FVB/NJ Akita mice: Temporal pattern
of kidney injury and urinary nephrin excretion. PLoS One.
7(e33942)2012.PubMed/NCBI View Article : Google Scholar
|
49
|
Lynch MR, Tran MT and Parikh SM: PGC1α in
the kidney. Am J Physiol Renal Physiol. 314:F1–F8. 2018.PubMed/NCBI View Article : Google Scholar
|
50
|
Tan J, Qiu K, Li M and Liang Y:
Double-negative feedback loop between long non-coding RNA TUG1 and
miR-145 promotes epithelial to mesenchymal transition and
radioresistance in human bladder cancer cells. FEBS Lett.
589:3175–3181. 2015.PubMed/NCBI View Article : Google Scholar
|
51
|
Cai H, Xue Y, Wang P, Wang Z, Li Z, Hu Y,
Li Z, Shang X and Liu Y: The long noncoding RNA TUG1 regulates
blood-tumor barrier permeability by targeting miR-144. Oncotarget.
6:19759–19779. 2015.PubMed/NCBI View Article : Google Scholar
|
52
|
Flores-Pérez A, Marchat LA,
Rodríguez-Cuevas S, Bautista-Piña V, Hidalgo-Miranda A, Ocampo EA,
Martínez M, Palma-Flores C, Fonseca-Sánchez MA, Astudillo-de la
Vega H, et al: Dual targeting of ANGPT1 and TGFBR2 genes by miR-204
controls angiogenesis in breast cancer. Sci Rep.
6(34504)2016.PubMed/NCBI View Article : Google Scholar
|
53
|
Maniyadath B, Chattopadhyay T, Verma S,
Kumari S, Kulkarni P, Banerjee K, Lazarus A, Kokane SS, Shetty T,
Anamika K and Kolthur-Seetharam U: Loss of hepatic oscillatory fed
microRNAs Abrogates Refed transition and causes liver dysfunctions.
Cell Rep. 26:2212–2226. 2019.PubMed/NCBI View Article : Google Scholar
|
54
|
Houzelle A, Dahlmans D, Nascimento EBM,
Schaart G, Jörgensen JA, Moonen-Kornips E, Kersten S, Wang X and
Hoeks J: MicroRNA-204-5p modulates mitochondrial biogenesis in
C2C12 myotubes and associates with oxidative capacity in humans. J
Cell Physiol. 235:9851–9863. 2020.PubMed/NCBI View Article : Google Scholar
|